NasdaqCM - Delayed Quote USD

Chemomab Therapeutics Ltd. (CMMB)

Compare
1.6300 +0.0600 (+3.82%)
At close: 4:00 PM EDT

Valuation Measures

Annual
Monthly
Currency in USD
Download
Current6/30/20243/31/20246/30/20233/31/2023
Market Cap 29.06M 12.97M 11.07M 15.54M 17.57M
Enterprise Value 16.69M -2.51M -8.33M -16.98M -22.11M
Trailing P/E -- -- -- -- --
Forward P/E -- -- -- -- --
PEG Ratio (5yr expected) -- -- -- -- --
Price/Sales -- -- -- -- --
Price/Book 2.91 0.97 0.65 0.56 0.49
Enterprise Value/Revenue -- -- -- -- --
Enterprise Value/EBITDA -- -- -- 2.08 2.45
3/31/2023 - 2/12/2019

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 12/31/2023
Most Recent Quarter (mrq) 6/30/2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm) 0.00%

Management Effectiveness

Return on Assets (ttm) -46.18%
Return on Equity (ttm) -93.80%

Income Statement

Revenue (ttm) --
Revenue Per Share (ttm) --
Quarterly Revenue Growth (yoy) --
Gross Profit (ttm) --
EBITDA -15.97M
Net Income Avi to Common (ttm) -15M
Diluted EPS (ttm) -1.0600
Quarterly Earnings Growth (yoy) --

Balance Sheet

Total Cash (mrq) 12.73M
Total Cash Per Share (mrq) 0.04
Total Debt (mrq) 360k
Total Debt/Equity (mrq) 3.60%
Current Ratio (mrq) 3.12
Book Value Per Share (mrq) 0.69

Cash Flow Statement

Operating Cash Flow (ttm) -16.13M
Levered Free Cash Flow (ttm) -11.36M

Trading Information

Stock Price History

Beta (5Y Monthly) 0.29
52 Week Range 3 89.16%
S&P 500 52-Week Change 3 39.07%
52 Week High 3 2.5500
52 Week Low 3 0.4200
50-Day Moving Average 3 1.5551
200-Day Moving Average 3 1.0072

Share Statistics

Avg Vol (3 month) 3 278.48k
Avg Vol (10 day) 3 174.83k
Shares Outstanding 5 18.51M
Implied Shares Outstanding 6 11.25M
Float 8 169.53M
% Held by Insiders 1 11.50%
% Held by Institutions 1 26.61%
Shares Short (9/30/2024) 4 72.49k
Short Ratio (9/30/2024) 4 0.25
Short % of Float (9/30/2024) 4 0.39%
Short % of Shares Outstanding (9/30/2024) 4 0.39%
Shares Short (prior month 8/30/2024) 4 215.17k

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 --
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 0.00%
Dividend Date 3 --
Ex-Dividend Date 4 --
Last Split Factor 2 1:16
Last Split Date 3 3/17/2021

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq?=?Most Recent Quarter
  • ttm?=?Trailing Twelve Months
  • yoy?=?Year Over Year
  • lfy?=?Last Fiscal Year
  • fye?=?Fiscal Year Ending

Related Tickers